The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival

Published:2020-08-11 Issue:6 Volume:4 Page:1128-1134
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Chahal Daljeet¹²^ORCID,Shamatutu Chris²,Salh Bill¹²,Davies Janine²³

Affiliation:

1. Division of Gastroenterology University of British Columbia Vancouver British Columbia Canada

2. Department of Medicine University of British Columbia Vancouver British Columbia Canada

3. Division of Medical Oncology BC Cancer Vancouver British Columbia Canada

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12405

Reference33 articles.

1. Cholangiocarcinoma: Current Knowledge and New Developments

2. Cholangiocarcinoma — evolving concepts and therapeutic strategies

3. Intrahepatic Cholangiocarcinoma

4. Risk factors for cholangiocarcinoma

5. Primary Sclerosing Cholangitis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review;eGastroenterology;2024-03

2. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices;Expert Review of Gastroenterology & Hepatology;2021-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3